1.
各组肿瘤组织中VEGF-C、VEGF-D、VEGFR-3表达阳性率，肿瘤组织微淋巴管密度以及循环肿瘤细胞数目
Positive expression rate of VEGF-C, VEGF-D, VEGFR-3, microlymphatic vessel density of tumor tissues and CTC number in each group
| Group | Sample size | Positive rate | MLVD | CTC number | ||
| VEGF-C | VEGF-D | VEGFR-3 | ||||
| VEGF: vascular endothelial growth factor; VEGFR: VEGF receptor; MLVD: microlymphatic vessel density; CTC: circulating tumor cell. | ||||||
| Control group | 7 | 94.3% | 91.4% | 88.6% | 9.94±0.19 | 25.43±1.98 |
| Cisplatin group | 7 | 91.4% | 88.6% | 85.7% | 9.29±0.29 | 7.14±1.95 |
| Endostar 1 | 7 | 65.7% | 62.9% | 68.6% | 6.30±0.34 | 15.13±2.17 |
| Endostar 2 | 7 | 48.6% | 42.6% | 51.4% | 5.55±0.39 | 10.63±1.60 |
| Endostar 3 | 7 | 31.4% | 28.6% | 34.3% | 4.33±0.29 | 6.25±1.67 |
| Endostar 1+Cisplatin | 7 | 62.9% | 57.1% | 65.7% | 6.39±0.29 | 3.13±0.83 |
| Endostar 2+Cisplatin | 7 | 45.7% | 40.0% | 48.6% | 5.48±0.31 | 1.00±0.76 |
| Endostar 3+Cisplatin | 7 | 28.6% | 25.7% | 31.4% | 4.35±0.25 | 0.13±0.35 |